You are here

UK

Pharma companies admit to sharing 'sensitive' info to keep prices high

Fierce Pharma

Tue, 09/24/19 - 10:06 am

King Pharmaceuticals

Alissa Healthcare

Factbox: Britain's insulin providers prepare for Brexit fallout

Yahoo/Reuters

Tue, 09/17/19 - 10:05 am

Vertex deal for Scotland — no deal for England

Endpoints

Fri, 09/13/19 - 10:22 am

Vertex Pharmaceuticals

cystic fibrosis

Drug companies pay for exclusive access to UK genetic data

Biopharma Dive

Thu, 09/12/19 - 11:35 am

genetic database

UK cost watchdog recommends Novartis' blindness therapy Luxturna

Yahoo/Reuters

Wed, 09/4/19 - 10:18 am

Spark Therapeutics

AliveCor launches six-lead ECG smartphone device in UK

Pharmaforum

Mon, 09/2/19 - 12:11 pm

GW confident epilepsy drug will get NHS funding despite NICE rejection

Pharmaforum

Fri, 08/23/19 - 12:08 pm

As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit

Fierce Biotech

Thu, 08/22/19 - 11:03 am

Brexit's Disruptive Impact On U.K. And European Prescription Drug Market

Forbes

Thu, 08/15/19 - 11:27 pm

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

Endpoints

Tue, 08/13/19 - 10:18 am

Vertex Pharmaceuticals

cystic fibrosis

Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning

Pharmaforum

Fri, 08/9/19 - 10:24 am

Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline

Fierce Biotech

Wed, 07/31/19 - 11:52 pm

artificial intelligence

cardiovascular disease

AstraZeneca to shell out £12M in severance dispute with workers at former England plant

Fierce Pharma

Thu, 07/18/19 - 12:00 pm

NICE recommends funding for psoriasis and type 1 diabetes drugs

Pharmaforum

Fri, 07/12/19 - 12:14 pm

U.K. launches subscription model to pay for antibiotics

BioCentury

Wed, 07/10/19 - 10:20 am

subscription model

How This Startup Is Applying Machine Learning To Disease Diagnosis

Forbes

Thu, 06/13/19 - 10:02 am

respiratory disease

artificial intelligence

machine learning

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout

Endpoints

Mon, 06/10/19 - 07:38 pm

Spark Therapeutics

BIO Roundup: Agenus, FDA, Merck’s Frazier and Much More

BioSpace

Sun, 06/9/19 - 01:49 pm

immuno-oncology

Orkambi parents start ‘buyers club’ to import generic version of CF drug

Pharmaforum

Wed, 06/5/19 - 10:11 am

cystic fibrosis

Vertex Pharmaceuticals

BI chief “regrets” Brexit, but continues to invest in UK

Pharmaforum

Thu, 04/18/19 - 11:05 am

Boehringer Ingelheim

Pages